Rahman Nafeesa, Dhadi Surendar Reddy, Deshpande Aparna, Ramakrishna Wusirika
Department of Biological Sciences, Michigan Technological University, Houghton, MI, USA.
Centre for Biochemistry and Microbial Sciences, Central University of Punjab, Bathinda, Punjab, India.
BMC Complement Altern Med. 2016 Nov 2;16(1):427. doi: 10.1186/s12906-016-1423-3.
Cancer is one of the leading cause of mortality. Even though efficient drugs are being produced to treat cancer, conventional medicines are costly and have adverse effects. As a result, alternative treatments are being tried due to their low cost and little or no adverse effects. Our previous study identified one such alternative in rice callus suspension culture (RCSC) which was more efficient than Taxol® and Etoposide, in reducing the viability of human colon and renal cancer cells in culture with minimal or no effect on a normal cell line.
In this study, we tested the effect of RCSC by studying the dynamics of lactate dehydrogenase (LDH) in lung cancer cell lines (NCI-H460 and A549), breast cancer cell lines (MDA-MB-231 and MCF-7) and colorectal cancer cell lines (SW620 and Caco-2) as well as their normal-prototypes. Complementary analysis for evaluating membrane integrity was performed by estimating LDH release in non-lysed cells and cell viability with WST-1 assay. Fluorescence microscopy with stains targeting nucleus and cell membrane as well as caspase 3/7 and Annexin V assays were performed. Real-time quantitative RT-PCR was performed to evaluate expression of 92 genes associated with molecular mechanisms of cancer in RCSC treated ling cancer cell line, NCI-H460 and its normal prototype, MRC-5. High performance liquid chromatography (HPLC) was used to collect RCSC fractions, which were evaluated on NCI-H460 for their anti-cancer activity.
Lower dilutions of RCSC showed maximum reduction in total LDH indicating reduced viability in majority of the cancer cell lines tested with minimal or no effect on normal cell lines compared to the control. Complementary analysis based on LDH release in non-lysed cells and WST-1 assay mostly supported total LDH results. RCSC showed the best effect on the lung non-small carcinoma cell line, NCI-H460. Fluorescence microscopy analyses suggested apoptosis as the most likely event in NCI-H460 treated with RCSC. Gene expression analysis identified significant upregulation of cJUN, NF-κB2 and ITGA2B in NCI-H460 which resulted most likely in the arrest of cell cycle progression and induction of apoptotic process. Further, HPLC-derived RCSC fractions were less effective in reducing cell viability than whole RCSC suggesting that a holistic approach of using RCSC is a better approach in inhibiting cancer cell proliferation.
RCSC was found to be an effective anti-cancer agent on cell lines of multiple cancer types with the best effect on lung cancer cell lines. A possible mechanism for the anticancer activity of RCSC is through induction of apoptosis as observed in the lung cancer cell line, NCI-H460.
癌症是主要的致死原因之一。尽管正在生产有效的抗癌药物,但传统药物价格昂贵且有副作用。因此,由于其低成本以及很少或没有副作用,人们正在尝试替代疗法。我们之前的研究在水稻愈伤组织悬浮培养(RCSC)中发现了一种这样的替代疗法,它在降低人结肠和肾癌细胞在培养中的活力方面比紫杉醇和依托泊苷更有效,对正常细胞系的影响最小或没有影响。
在本研究中,我们通过研究肺癌细胞系(NCI - H460和A549)、乳腺癌细胞系(MDA - MB - 231和MCF - 7)以及结肠癌细胞系(SW620和Caco - 2)及其正常原型中乳酸脱氢酶(LDH)的动态变化来测试RCSC的效果。通过估计未裂解细胞中的LDH释放以及用WST - 1法检测细胞活力来进行评估膜完整性的补充分析。进行了针对细胞核和细胞膜的染色的荧光显微镜检查以及半胱天冬酶3/7和膜联蛋白V检测。进行实时定量RT - PCR以评估在RCSC处理的肺癌细胞系NCI - H460及其正常原型MRC - 5中与癌症分子机制相关的92个基因的表达。使用高效液相色谱(HPLC)收集RCSC馏分,并在NCI - H460上评估其抗癌活性。
较低稀释度的RCSC显示总LDH的最大降低,表明在所测试的大多数癌细胞系中活力降低,与对照相比对正常细胞系的影响最小或没有影响。基于未裂解细胞中LDH释放和WST - 1检测的补充分析大多支持总LDH结果。RCSC对肺非小细胞癌细胞系NCI - H460显示出最佳效果。荧光显微镜分析表明凋亡是RCSC处理的NCI - H460中最可能发生的事件。基因表达分析确定NCI - H460中cJUN、NF - κB2和ITGA2B显著上调,这最有可能导致细胞周期进程停滞和凋亡过程的诱导。此外,HPLC衍生的RCSC馏分在降低细胞活力方面比整个RCSC效果更差,这表明使用RCSC的整体方法在抑制癌细胞增殖方面是一种更好的方法。
发现RCSC对多种癌症类型的细胞系是一种有效的抗癌剂,对肺癌细胞系效果最佳。RCSC抗癌活性的一种可能机制是通过诱导凋亡,如在肺癌细胞系NCI - H460中观察到的那样。